Zusammenfassung aller wichtigen Infos:
Bitte PDF im Vollbildmodus ansehen oder ausdrucken.
Flyer

---

Zusammensetzung (in 1 Kapsel):

• Vitamin А (Beta-Carotin und natürliche Karotionide – Alpha-Carotin, Zeaxanthin, Kryptoxanthin, Lutein) – 2500 IE
• Vitamin С (Ascorbyl Palmitat) – 110 mg
• Vitamin Е (dl-Alpha-Tocopherolacetat) – 26 МЕ
• Vitamin В3 (Niacin und Niaciamid) – 4 mg
• Folsäure – 40 mg
• Vitamin В12 (Cyanocobalamin) – 2 mg

Exklusive Formel:

• Chelate der Aminosäuren:
• Magnesium – 31.7 mg
• Zink – 2 mg
• Selen – 12 mg
• Kalium (Kaliumzitrat) – 20 mg

Exklusive Formel – 100 mg:

• Koenzym Q10 (Ubidecarenone)
• L-Carnitin, (Carnitine)
• Extrakt der roten Weinrebe (Vitis vinifera)
  standartisirter Extrakt aus den Blättern von Ginkgo biloba (Ginkgo biloba)
  (24% Ginkgo-Flavonglykoside und 6% Terpenlactone)
• Extrakt des deodorierten Knoblauchs (Allium sativum) (10,000 ppm Allicin)
• Konzentrat de Hagedornbeeren (Crataegus spp).

Beschreibung der Studie: Herz- und Kreislauf*
Jialal I and Fuller CJ. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Can J Cardiol 1995;11 Suppl G:97G-103G.

Angemeldete Benutzer sehen mehr Anwendungsempfehlungen.

Literaturnachweise:

1. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health, September 2002. NIH Publication No. 02-5215.
2. Gey KF. Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Biofactors 1998;7:113-74.
3. Brown WV. Niacin for lipid disorders. Postgrad Med 1995;98:185–93 [review].
4. Guyton JR. Effect of niacin on atherosclerotic cardiovascular disease. Am J Cardiol 1998;82(12A):18U–23U [review].
5. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
6. Bottiglieri T, Reynolds EH, Laundy M. Folate in CSF and age. J Neurol Neurosurg Psychiatry 2000; 69: 562
7. Homocysteine Lowering Trialists‘ Collaboration: Lowering blood homocysteine with folic acid based supplements: metaanalysis of randomised trials. BMJ 1998;316:894-8.
8. Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. National Academy Press. Washington, DC, 1999.
9. Clostre F. From the body to the cell membranes: the different levels of pharmacological action of Ginkgo biloba extract. In: Rokan (Ginkgo biloba): Recent Results in Pharmacology and Clinic.Fünfgeld EW, ed. Berlin: Springer-Verlag, 1988, 180-98.
10. Jialal I and Fuller CJ. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Can J Cardiol 1995;11 Suppl G:97G-103G.
11. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9
12. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994;139:1180-9.
13. Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, McPartlin J, Scott J. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 2001;161:695-700.
14. Pittler MH , Schmidt K, Ernst E. – Complementary Medicine, Peninsula Medical School, Universities of Exeter and Plymouth , 25 Victoria Park Road , Exeter EX2 4NT, United Kingdom. Am J Med. 2003 Jun 1 ; 114 (8): 665-74